Treatment Overview
High-Risk Patient Screening for prostate cancer in Korea is a comprehensive diagnostic approach for men with elevated risk factors, such as family history, genetic mutations, elevated PSA levels, or previous abnormal findings. This screening combines advanced blood tests, imaging, and personalized evaluations to detect prostate cancer at an early stage and guide timely interventions.
Korean hospitals offer state-of-the-art facilities and experienced urologists for accurate assessment and international patient support.
Purpose & Benefits
The main purposes of high-risk screening are:
- Detect prostate cancer early in individuals at elevated risk
- Guide personalized diagnostic and monitoring strategies
- Reduce unnecessary procedures while focusing on clinically significant disease
Benefits include:
- Comprehensive risk evaluation using PSA, PHI, 4Kscore, mpMRI, and genetic testing
- Early detection of aggressive prostate cancer
- Minimally invasive and outpatient-friendly procedures
- Personalized monitoring and follow-up plans
- Integration of advanced imaging and targeted biopsy for accuracy
Ideal Candidates
High-risk screening is recommended for men who:
- Have a family history of prostate or related cancers
- Carry or suspect hereditary gene mutations (e.g., BRCA1/2, HOXB13)
- Have elevated or fluctuating PSA levels
- Previously had a negative biopsy but persistent suspicion
- Are over 45 years old with additional risk factors
Korean urologists assess patient history, genetic predisposition, and prior test results to design a customized screening plan.
Possible Risks & Complications
High-risk screening is generally safe, but considerations include:
- Mild discomfort from blood draws or DRE
- Anxiety while awaiting test results
- Rare false-positive findings leading to further testing
- Minimal risks associated with imaging contrast agents or biopsy procedures
Techniques & Technology Used
Korean hospitals use advanced technologies for high-risk patient screening:
- Blood tests: PSA, Free PSA, PHI, 4Kscore
- Digital Rectal Exam (DRE) for prostate assessment
- Multiparametric MRI (mpMRI) for detailed imaging of suspicious lesions
- Genetic risk assessment for hereditary cancer predisposition
- Targeted biopsy planning using MRI/Ultrasound fusion
- Certified laboratories and imaging centers ensuring precise results
These technologies provide a complete picture of prostate health and cancer risk.
Treatment Process in Korea
- Consultation & Risk Evaluation – Review family history, PSA levels, genetics, and prior results
- Blood Tests & Physical Examination – PSA, PHI, 4Kscore, and DRE as indicated
- Imaging Assessment – mpMRI or fusion imaging for high-risk patients
- Targeted Biopsy Planning – Guided by imaging if suspicious lesions are detected
- Result Interpretation & Follow-Up – Personalized recommendations for monitoring, intervention, or preventive measures
Medical tourism coordinators assist international patients with scheduling, translation, and follow-up services.
Recovery & After-Care
- Minimal recovery for blood tests, DRE, and imaging
- Resume normal activities immediately
- Short rest may be required if biopsy is performed
- Follow-up consultations based on screening outcomes
Results & Interpretation
High-risk patient screening provides:
- Comprehensive assessment of prostate cancer risk
- Identification of suspicious lesions requiring biopsy
- Guidance for active surveillance, treatment, or preventive interventions
- Personalized recommendations based on genetic and clinical data
Early detection improves treatment outcomes and long-term prostate health.
Why Korea Is a Top Destination
- State-of-the-art laboratories and imaging centers
- Experienced urologists and genetic counselors
- Advanced fusion-guided biopsy and mpMRI capabilities
- Fast, accurate results suitable for international patients
- English-language support and medical tourism services
- Affordable and high-quality compared to Western countries
Cost Range
Typical costs for high-risk patient screening in Korea:
₩500,000 – ₩2,500,000 KRW (~$400–$2,000 USD)
Costs vary depending on:
- Number of tests included (PSA, PHI, 4Kscore, mpMRI, genetic testing)
- Hospital or clinic grade
- Consultation and follow-up services
Popular Clinics in Korea
- Seoul National University Hospital – High-Risk Prostate Screening Center
- Samsung Medical Center – Advanced Urology Diagnostics & Genetic Testing
- Asan Medical Center – Comprehensive Prostate Screening
- Gangnam Severance Hospital – International Patient Screening Services
- Korea University Anam Hospital – High-Risk Screening & Genetic Counseling
- JK Urology & Men’s Health Clinics – Personalized Prostate Screening & International Support
